TLR2 biomarker reagents for research and commercial licensing

Human soluble toll-like receptor 2 (sTLR2) is a biomarker associated with inflammation and sepsis. A selection of monoclonal and polyclonal antibodies have been developed, specific for human sTLR2, and are available for research and commercial use.

Licensing opportunities are available for the following reagents and assays;

• Four monoclonal antibodies with specific reactivity to sTLR2
• Monoclonal antibody pair for use in immunometric assays for the detection of human sTLR2

A pair of sTLR2 monoclonal antibodies have been successfully used in immunochromatographic lateral flow assays using human serum, and in ELISA format.

For further information for research or commercial use please contact us.